Salem Investment Counselors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-30
Closed -$5.39K 1220
2023
Q4
$5.39K Hold
30
﹤0.01% 896
2023
Q3
$4.77K Hold
30
﹤0.01% 901
2023
Q2
$4.24K Buy
+30
New +$4.81K ﹤0.01% 935

Other funds holding RGEN

Salem Investment Counselors's RGEN Position: Q1 2024 in Review

Salem Investment Counselors sold out of Repligen (RGEN) in Q1 2024, closing a stake of 30 shares — an estimated $5.39K sold.

Salem Investment Counselors first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $5.39K in Q4 2023. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Salem Investment Counselors reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
  • Salem Investment Counselors sold 30 Repligen shares in Q1 2024, an estimated $5.39K.
  • Salem Investment Counselors first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
  • Salem Investment Counselors's Repligen position peaked at $5.39K in Q4 2023.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Salem Investment Counselors's 13F filing for Q1 2024, filed 11 Apr 2024.